ES534681A0 - Procedimiento para preparar (1, 2, 4) triazol (1, 5-c)pirimidin-2-aminas 5-sustituidas - Google Patents

Procedimiento para preparar (1, 2, 4) triazol (1, 5-c)pirimidin-2-aminas 5-sustituidas

Info

Publication number
ES534681A0
ES534681A0 ES534681A ES534681A ES534681A0 ES 534681 A0 ES534681 A0 ES 534681A0 ES 534681 A ES534681 A ES 534681A ES 534681 A ES534681 A ES 534681A ES 534681 A0 ES534681 A0 ES 534681A0
Authority
ES
Spain
Prior art keywords
substituted
amines
pirimidin
triazol
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES534681A
Other languages
English (en)
Spanish (es)
Other versions
ES8505684A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES8505684A1 publication Critical patent/ES8505684A1/es
Publication of ES534681A0 publication Critical patent/ES534681A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES534681A 1983-07-28 1984-07-27 Procedimiento para preparar (1, 2, 4) triazol (1, 5-c)pirimidin-2-aminas 5-sustituidas Granted ES534681A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51825083A 1983-07-28 1983-07-28

Publications (2)

Publication Number Publication Date
ES8505684A1 ES8505684A1 (es) 1985-06-16
ES534681A0 true ES534681A0 (es) 1985-06-16

Family

ID=24063190

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534681A Granted ES534681A0 (es) 1983-07-28 1984-07-27 Procedimiento para preparar (1, 2, 4) triazol (1, 5-c)pirimidin-2-aminas 5-sustituidas

Country Status (18)

Country Link
EP (1) EP0132851B1 (en:Method)
JP (1) JPS6056983A (en:Method)
KR (1) KR900004000B1 (en:Method)
AT (1) ATE46907T1 (en:Method)
AU (1) AU570989B2 (en:Method)
CA (1) CA1224785A (en:Method)
DD (1) DD220780A5 (en:Method)
DE (1) DE3427823A1 (en:Method)
DK (1) DK365284A (en:Method)
ES (1) ES534681A0 (en:Method)
GR (1) GR82440B (en:Method)
HK (1) HK4391A (en:Method)
HU (1) HU190936B (en:Method)
IE (1) IE57939B1 (en:Method)
IL (1) IL72529A (en:Method)
NZ (1) NZ208996A (en:Method)
PL (1) PL248968A1 (en:Method)
ZA (1) ZA845842B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0244948A3 (en) * 1986-04-30 1989-03-15 Schering Agrochemicals Limited Triazolopyrimidine herbicides
CA2284737C (en) 1997-03-24 2007-03-13 Kyowa Hakko Kogyo Co., Ltd. [1,2,4]triazolo[1,5-c]pyrimidine derivatives
WO2000017201A1 (en) 1998-09-22 2000-03-30 Kyowa Hakko Kogyo Co., Ltd. [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES
GB0719803D0 (en) * 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
TWI462920B (zh) 2009-06-26 2014-12-01 葛萊伯格有限公司 用於治療退化性及發炎疾病之新穎化合物
PL2576558T3 (pl) * 2010-05-25 2015-05-29 Dow Agrosciences Llc Sposób wytwarzania 5-podstawionych 8-alkoksy[1,2,4]triazolo-[1,5-c]pirymidyno-2-amin
KR102629882B1 (ko) * 2023-05-10 2024-01-29 김황래 조적수평장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3045015A (en) * 1958-10-03 1962-07-17 Ici Ltd Triazolo-[2, 3-c]-pyrimidines
US3053844A (en) * 1959-04-13 1962-09-11 Ici Ltd Mono-acyl derivatives of s-triazolo [2, 3-c] pyrimidines
US3046276A (en) * 1959-06-15 1962-07-24 Ici Ltd S-triazolo-[2, 3-c] pyrimidine derivatives
US4269980A (en) * 1979-12-17 1981-05-26 American Cyanamid Company (Substituted-phenyl)-1,2,4-triazolo[4,3-c]pyrimidines and (substituted-phenyl)-1,2,4-triazolo[1,5-c]pyrimidines

Also Published As

Publication number Publication date
IE841943L (en) 1985-01-25
DK365284D0 (da) 1984-07-26
GR82440B (en:Method) 1984-12-13
ATE46907T1 (de) 1989-10-15
CA1224785A (en) 1987-07-28
ES8505684A1 (es) 1985-06-16
DK365284A (da) 1985-01-29
KR900004000B1 (ko) 1990-06-07
AU570989B2 (en) 1988-03-31
NZ208996A (en) 1989-08-29
ZA845842B (en) 1985-03-27
PL248968A1 (en) 1985-10-22
JPH0447671B2 (en:Method) 1992-08-04
EP0132851A1 (en) 1985-02-13
IE57939B1 (en) 1993-05-19
KR850001215A (ko) 1985-03-16
AU3124084A (en) 1985-01-31
EP0132851B1 (en) 1989-10-04
HK4391A (en) 1991-01-18
DE3427823A1 (de) 1985-02-07
JPS6056983A (ja) 1985-04-02
IL72529A (en) 1988-05-31
IL72529A0 (en) 1984-11-30
HUT34752A (en) 1985-04-28
HU190936B (en) 1986-12-28
DD220780A5 (de) 1985-04-10

Similar Documents

Publication Publication Date Title
NO852558L (no) Fremgangsmaate ved fremstilling av benzodiazepinanaloger.
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
FI870113A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4,5,6-substioitujenN-(substituoitu-fenyyli)-2-pyrimidiiniamiinien valmistamiseksi
BG60307B2 (en) Method for obtaining of substituted two-ring compounds
GR79463B (en:Method)
DK227183D0 (da) Fremgangsmade til fremstilling af imidazo (1,2-c)-pyrazolo(3,4-e) pyrimidiner med den almene formel i
ES546971A0 (es) Procedimiento para preparar derivados de bencilftalazinona sustituidos
ES8504805A1 (es) Un procedimiento para la preparacion de imidazobenzodiacepinas
IE830262L (en) Fungicidal indanylbenzamides
DK365284D0 (da) 5-substituerede (1,2,4)triazolo(1,5-c)pyrimidin-2-aminer
ES545973A0 (es) Procedimiento para preparar derivados de imidazo (1,5-a)pi- rimidina
ES545009A0 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
ES538398A0 (es) Procedimiento para la obtencion de tiolan-2,4-dion-3-carboxamidas
NZ197800A (en) 2,3,6,7-tetrahydro-5h-thiazolo(3,2-a)pyrimid-5-ones
ES544772A0 (es) Procedimiento para preparar derivados de pirazol(1,5-a) pi- ridina
ES546555A0 (es) Procedimiento para la obtencion de benzodisultamas
ATE5720T1 (de) 2-pyridyloxyacetanilid-verbindungen, verfahren zu ihrer herstellung und ihre verwendung.
IE830256L (en) Alkanediones and imidazoles.
IE812607L (en) Heterobicyclic compounds
ES2053808T3 (es) Nuevos compuestos azolicos.
AR227783A1 (es) Procedimiento para preparar derivados de 4,5,7,8-tetrahidro-4,4,8,8-tetrametil-1-h-tiepin(4,5-d)imidazol
DE3461189D1 (en) New 3-alkylthio-2-o-carbamoyl-propane-1.2-diol-1-o-phosphocholines, and processes for their preparation
BG37524A3 (en) Method for preparing 1, 5- benzothiazepines derivatives
ES538693A0 (es) Procedimiento para la obtencion de compuestos 2,2' dibenzoburilicos

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401